Temsirolimus, a rapamycin (sirolimus) derivative, also known as CCI-779, is an mTOR inhibitor with anti-cancer activity. Temsirolimus down-regulated the mTOR signaling intermediate phospho-S6 in xenografted human ALL. Temsirolimus has been shown to reverse cisplatin resistance in small cell lung cancer cell lines selected for cisplatin resistance and in cell lines derived from patients who failed cisplatin therapy. _x000D_
Cerere de ofertă
Indisponibil
Număr Catalog 421-27024CategorieAfaceri și industrie > Știință și laboratorFurnizorBPS BioscienceGentaurDimensiune10 mgTipsingle